Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DC-HIV04 Therapeutic Vaccine in HIV
NCT03758625Phase 1Completed
- Start
- Jan 2019
- Primary completion
- Feb 2025
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in human immunodeficiency virus infection (HIV) (6 arms). Primary endpoints: Safety and tolerability of six immunizations and Efficacy of six immunizations. Started Jan 2019; status: completed.
02
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT03758625.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03758625.